Synergetics USA, Inc. (NASDAQ:SURG) delivered a profit and met Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.
Synergetics USA, Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share decreased 25% to $0.06 in the quarter versus EPS of $0.08 in the year-earlier quarter.
Revenue: Rose 5.93% to $17.86 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Synergetics USA, Inc. reported adjusted EPS income of $0.06 per share. By that measure, the company met the mean analyst estimate of $0.06. It beat the average revenue estimate of $17.01 million.
Quoting Management: “We were pleased with our fourth quarter revenue performance, particularly in the U.S., where we saw improving trends in our ophthalmic sales of both new and base business products. Commercialization of the VersaVIT™ system remains on-track as we continue to establish a solid installed base. Fourth quarter results also benefitted from strong demand from our OEM partners,” said David M. Hable, the Company’s President and Chief Executive Officer. “Our international results were softer than anticipated, driven by ongoing weakness in our base business and lower contributions from emerging markets compared to last year. The recent acquisition of our U.K. distribution partner, M.I.S.S. Ophthalmics, contributed modestly to international revenues in the period, and we look forward to incremental contributions in fiscal 2014.”
Key Stats (on next page)…